Status:
RECRUITING
Suboccipital Muscle Inhibition Technique vs Rocabado Exercises on Cervicogenic Headache
Lead Sponsor:
Riphah International University
Conditions:
Cervicogenic Headache
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
The purpose of the study is to explore the effectiveness of Suboccipital muscle inhibition technique vs Rocabado exercises on cervicogenic headache. A randomized control trial was conducted at Nationa...
Detailed Description
Cervicogenic headache is a type of secondary headache that originates from cervical spine dysfunction, particularly involving the upper cervical segments. It is frequently unilateral and is often acco...
Eligibility Criteria
Inclusion
- Participants with a history of chronic CGH (\>3 months)
- CGH pain intensity between 3 and 8 on NPRS
- Participants who had a unilateral headache that do not shift side (ipsilateral neck pain/stiffness)
- Pain at least once a week in the previous three months, chronic, episodic, and duration one hour to weeks (non-throbbing pain starts in the neck).
- CGH due to cervical spine dysfunction
- Neck pain followed by headache
- Patients with neck stiffness and movement restriction were included.
- Flexion Rotation Test results that are positive with a restriction of more than 10 degrees.
Exclusion
- Participants with other types of headache migraine, sinus, tumor, neural, or temporomandibular joint issues)
- Cervicogenic headache patients with mixed headache or any diagnosed serious pathology of alar ligament and vertebra basilar artery insufficiency
- Any contraindications to manual and manipulative therapy (fracture, instability, osteoporosis, arthropathy, or neural symptoms)
- Using analgesics or corticosteroids
- Metastasis
- Cardiac conditions (stroke, hypertension, or syncope)
- Neurological conditions (radiculopathy, myelopathy, or disc problems)
- Spinal cord problem
- Previous brain and spinal cord surgery
- Occlusal splints or any surgery in Temporomandibular joint area.
Key Trial Info
Start Date :
January 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06938256
Start Date
January 3 2025
End Date
July 15 2025
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Rehabilitation and Medicine
Islamabad, Pakistan, 44000